A. J. Davison, Herpesvirus systematics, Vet. Microbiol, vol.143, pp.52-69, 2010.

P. Wohlsein, A. Lehmbecker, I. Spitzbarth, D. Algermissen, W. Baumgärtner et al., Fatal epizootic equine herpesvirus 1 infections in new and unnatural hosts, Vet. Microbiol, vol.149, pp.456-460, 2011.

E. S. Ibrahim, M. Kinoh, T. Matsumura, M. Kennedy, G. P. Allen et al., Genetic relatedness and pathogenicity of equine herpesvirus 1 isolated from onager, zebra and gazelle, Arch. Virol, vol.152, pp.245-255, 2007.

J. R. Patel, N. Edington, and J. A. Mumford, Variation in cellular tropism between isolates of Equine herpesvirus-1 in Foals, Arch. Virol, vol.74, pp.41-51, 1982.

J. H. Kydd, K. C. Smith, D. Hannant, G. J. Livesay, and J. A. Mumford, Distribution of Equid herpesvirus-1 (EHV-1) in the respiratory tract of ponies: Implications for vaccination strategies, Equine Vet. J, vol.26, pp.466-469, 1994.

J. H. Kydd, K. C. Smith, D. Hannant, G. J. Livesay, and J. A. Mumford, Distribution of Equid herpesvirus-1 (EHV-1) in respiratory tract associated lymphoid tissue: Implications for cellular immunity, Equine Vet. J, vol.26, pp.470-473, 1994.

N. Edington, C. G. Bridges, and J. R. Patel, Endothelial cell infection and thrombosis in paralysis caused by equid herpesvirus-1: Equine stroke, Arch. Virol, vol.90, pp.111-124, 1986.

N. Edington, B. Smyth, and L. Griffiths, The role of endothelial cell infection in the endometrium, placenta and foetus of equid herpesvirus 1 (EHV-1) Abortions, J. Comp. Pathol, vol.104, pp.379-387, 1991.

G. P. Allen, Respiratory Infections by Equine Herpesvirus Types 1 and 4. In Equine Respiratory Diseases; International Veterinary Information Service, 2002.

R. Paillot, R. Case, J. Ross, R. Newton, and J. Nugent, Equine Herpes Virus-1: Virus, Immunity and Vaccines, vol.2, pp.68-91, 2008.

H. M. Welch, C. G. Bridges, A. M. Lyon, L. Griffiths, and N. Edington, Latent equid herpesviruses 1 and 4: Detection and distinction using the polymerase chain reaction and co-cultivation from lymphoid tissues, J. Gen. Virol, vol.73, pp.261-268, 1992.

J. D. Slater, K. Borchers, A. M. Thackray, and H. J. Field, The trigeminal ganglion is a location for equine herpesvirus 1 latency and reactivation in the horse, J. Gen. Virol, vol.75, 1994.

N. Edington, C. G. Bridges, and A. Huckle, Experimental reactivation of equid herpesvirus 1 (EHV 1) following the administration of corticosteroids, Equine Vet. J, vol.17, pp.369-372, 1985.

G. P. Allen, Antemortem detection of latent infection with neuropathogenic strains of equine herpesvirus-1 in horses, Am. J. Vet. Res, vol.67, 2006.

N. Edington, H. M. Welch, and L. Griffiths, The prevalence of latent Equid herpesviruses in the tissues of 40 abattoir horses, Equine Vet. J, vol.26, pp.140-142, 1994.

E. A. Telford, M. S. Watson, K. Mcbride, and A. J. Davison, The DNA sequence of equine herpesvirus-1, Virology, vol.189, pp.304-316, 1992.

J. Nugent, I. Birch-machin, K. C. Smith, J. A. Mumford, Z. Swann et al., Analysis of Equid Herpesvirus 1 Strain Variation Reveals a Point Mutation of the DNA Polymerase Strongly Associated with Neuropathogenic versus Nonneuropathogenic Disease Outbreaks, J. Virol, vol.80, pp.4047-4060, 2006.

L. B. Goodman, A. Loregian, G. A. Perkins, J. Nugent, E. L. Buckles et al., A Point Mutation in a Herpesvirus Polymerase Determines Neuropathogenicity, PLoS Pathog, vol.3, 2007.

G. R. Van-de-walle, R. Goupil, C. Wishon, A. Damiani, G. A. Perkins et al., A Single-Nucleotide Polymorphism in a Herpesvirus DNA Polymerase Is Sufficient to Cause Lethal Neurological Disease, J. Infect. Dis, pp.20-25, 0200.

D. P. Lunn, N. Davis-poynter, M. J. Flaminio, D. W. Horohov, K. Osterrieder et al., Equine Herpesvirus-1 Consensus Statement, J. Vet. Intern. Med, vol.23, pp.450-461, 2009.

S. Pronost, A. Léon, L. Legrand, C. Fortier, F. Miszczak et al., Neuropathogenic and non-neuropathogenic variants of equine herpesvirus 1 in France, Vet. Microbiol, vol.145, pp.329-333, 2010.
URL : https://hal.archives-ouvertes.fr/hal-02946328

G. Sutton, M. Garvey, A. Cullinane, M. Jourdan, C. Fortier et al., Molecular Surveillance of EHV-1 Strains Circulating in France during and after the Major, Normandy Involving Respiratory Infection, Neurological Disorder, and Abortion. Viruses, vol.11, p.916, 2009.
URL : https://hal.archives-ouvertes.fr/hal-02351539

G. P. Allen and C. C. Breathnach, Quantification by real-time PCR of the magnitude and duration of leucocyte-associated viraemia in horses infected with neuropathogenic vs. non-neuropathogenic strains of EHV-1, Equine Vet. J, vol.38, pp.252-257, 2010.

J. G. Heldens, D. Hannant, A. A. Cullinane, M. J. Prendergast, J. A. Mumford et al., Clinical and virological evaluation of the efficacy of an inactivated EHV1 and EHV4 whole virus vaccine (Duvaxyn EHV1,4). Vaccination/challenge experiments in foals and pregnant mares, Vaccine, vol.19, pp.4307-4317, 2001.

L. Goodman, B. Wagner, M. Flaminio, K. Sussman, S. Metzger et al., Comparison of the efficacy of inactivated combination and modified-live virus vaccines against challenge infection with neuropathogenic equine herpesvirus type 1 (EHV-1), Vaccine, vol.24, pp.3636-3645, 2006.

L. S. Goehring, B. Wagner, R. Bigbie, S. B. Hussey, S. Rao et al., Control of EHV-1 viremia and nasal shedding by commercial vaccines, Vaccine, vol.28, pp.5203-5211, 2010.

C. J. Thieulent, E. S. Hue, C. I. Fortier, P. Dallemagne, S. Zientara et al., Screening and evaluation of antiviral compounds against Equid alpha-herpesviruses using an impedance-based cellular assay, Virology, vol.526, pp.105-116, 2019.
URL : https://hal.archives-ouvertes.fr/hal-01968305

B. Garre, K. Vandermeulen, J. Nugent, J. Neyts, S. Croubels et al., In vitro susceptibility of six isolates of equine herpesvirus 1 to acyclovir, ganciclovir, cidofovir, adefovir, PMEDAP and foscarnet, Vet. Microbiol, vol.122, pp.43-51, 2007.

L. K. Maxwell, B. G. Bentz, D. W. Bourne, and R. S. Erkert, Pharmacokinetics of valacyclovir in the adult horse, J. Vet. Pharmacol. Ther, vol.31, pp.312-320, 2008.

R. Paillot, G. Sutton, C. Thieulent, C. Marcillaud-pitel, and S. Pronost, New EHV-1 variant identified, Vet. Rec, vol.2020
URL : https://hal.archives-ouvertes.fr/hal-02875094

I. S. Diallo, G. Hewitson, L. Wright, B. J. Rodwell, and B. G. Corney, Detection of equine herpesvirus type 1 using a real-time polymerase chain reaction, J. Virol. Methods, vol.131, pp.92-98, 2006.

S. Pronost, L. Legrand, P. Pitel, B. Wegge, J. Lissens et al., Outbreak of Equine Herpesvirus Myeloencephalopathy in France: A Clinical and Molecular Investigation: Outbreak of EHV-1 myeloencephalopathy, Transbound. Emerg. Dis, vol.59, pp.256-263, 2012.

G. P. Allen, Development of a Real-Time Polymerase Chain Reaction Assay for Rapid Diagnosis of Neuropathogenic Strains of Equine Herpesvirus-1, J. Vet. Diagn. Investig, vol.19, pp.69-72, 2007.

T. Hall, BioEdit: A user-friendly biological sequence alignment editor and analysis program for Windows 95/98/NT, Nucl. Acids Symp. Ser, vol.41, pp.95-98, 1999.

J. W. Leigh and D. Bryant, POPART: Full-feature software for haplotype network construction, Methods Ecol. Evol, vol.6, pp.1110-1116, 2015.

M. Garvey, R. Lyons, R. Hector, C. Walsh, S. Arkins et al., Molecular Characterisation of Equine Herpesvirus 1 Isolates from Cases of Abortion, Respiratory and Neurological Disease in Ireland between, vol.8, 1990.

D. H. Huson and D. Bryant, Application of Phylogenetic Networks in Evolutionary Studies, Mol. Biol. Evol, vol.23, pp.254-267, 2006.

L. A. Kelley, S. Mezulis, C. M. Yates, M. N. Wass, and M. J. Sternberg, The Phyre2 web portal for protein modeling, prediction and analysis, Nat. Protoc, vol.10, pp.845-858, 2015.

E. Hue, E. Richard, C. Fortier, G. Fortier, R. Paillot et al., Equine PBMC Cytokines Profile after In Vitro ?-and ?-EHV Infection: Efficacy of a Parapoxvirus Ovis Based-Immunomodulator Treatment, vol.5, 2017.
URL : https://hal.archives-ouvertes.fr/hal-01875682

M. A. Ramakrishnan, Determination of 50% endpoint titer using a simple formula, vol.5, pp.1160-1182, 2016.

Y. Fang, P. Ye, X. Wang, X. Xu, and W. Reisen, Real-time monitoring of flavivirus induced cytopathogenesis using cell electric impedance technology, J. Virol. Methods, vol.173, pp.251-258, 2011.

, OIE World Organization for Animal Health, p.30, 2020.

D. Garrett, F. Montesso, S. Fougerolle, M. R. Lopez-alvarez, I. Birand et al., Refinement of the equine influenza model in the natural host: A meta-analysis to determine the benefits of individual nebulisation for experimental infection and vaccine evaluation in the face of decreased strain pathogenicity, Vet. Microbiol, vol.211, pp.150-159, 2017.
URL : https://hal.archives-ouvertes.fr/hal-02167928

. Pfie-infectiology-of-farm, Model and Wild Animals Facility, 2020.

R. Paillot, L. Prowse, C. Donald, E. Medcalf, F. Montesso et al., Efficacy of a whole inactivated EI vaccine against a recent EIV outbreak isolate and comparative detection of virus shedding, Vet. Immunol. Immunopathol, vol.136, pp.272-283, 2010.

G. B. Elion, The biochemistry and mechanism of action of acyclovir, J. Antimicrob. Chemother, vol.12, pp.9-17, 1983.

T. Matthews and R. Boehme, Antiviral Activity and Mechanism of Action of Ganciclovir, Clin. Infect. Dis, vol.10, pp.490-494, 1988.

R. Sheaff, D. Ilsley, and R. Kuchta, Mechanism of DNA polymerase alpha inhibition by aphidicolin, Biochemistry, vol.30, pp.8590-8597, 1991.

, StatGraphics Plus, 2020.

N. A. Bryant, G. S. Wilkie, C. A. Russell, L. Compston, D. Grafham et al., Genetic diversity of equine herpesvirus 1 isolated from neurological, abortigenic and respiratory disease outbreaks, Transbound Emerg. Dis, vol.65, pp.817-832, 2018.

W. Dimock and P. Edwards, Is there a filterable virus of abortion in mares, Bull. Ky. Agric. Exp. Stn, vol.333, pp.291-301, 1933.

A. C. Gryspeerdt, A. P. Vandekerckhove, B. Garré, F. Barbé, G. R. Van-de-walle et al., Differences in replication kinetics and cell tropism between neurovirulent and non-neurovirulent EHV1 strains during the acute phase of infection in horses, Vet. Microbiol, vol.142, pp.242-253, 2010.
URL : https://hal.archives-ouvertes.fr/hal-00587285

J. E. Wellington, D. N. Love, and J. M. Whalley, Evidence for involvement of equine herpesvirus 1 glycoprotein B in cell-cell fusion, Arch. Virol, vol.141, pp.167-175, 1996.

K. C. Poelaert, J. Van-cleemput, K. Laval, H. W. Favoreel, L. Couck et al., Equine Herpesvirus 1 Bridles T Lymphocytes to Reach Its Target Organs, J. Virol, vol.93, pp.2098-2116, 2019.

K. Laval, J. Van-cleemput, K. C. Poelaert, I. K. Brown, and H. J. Nauwynck, Replication of neurovirulent equine herpesvirus type 1 (EHV-1) in CD172a+ monocytic cells, Comp. Immunol. Microbiol. Infect. Dis, vol.50, pp.58-62, 2017.

G. A. Perkins, L. B. Goodman, K. Tsujimura, G. R. Van-de-walle, S. G. Kim et al., Investigation of the prevalence of neurologic equine herpes virus type 1 (EHV-1) in a 23-year retrospective analysis, Vet. Microbiol, vol.139, pp.375-378, 1984.

M. A. Vissani, M. L. Becerra, C. Olguín-perglione, M. S. Tordoya, S. Miño et al., Neuropathogenic and non-neuropathogenic genotypes of Equid Herpesvirus type 1 in Argentina, Vet. Microbiol, vol.139, pp.361-364, 2009.

A. Fritsche and K. Borchers, Detection of neuropathogenic strains of Equid Herpesvirus 1 (EHV-1) associated with abortions in Germany, Vet. Microbiol, vol.147, pp.176-180, 2011.

N. Pusterla, K. Hatch, B. Crossley, C. Wademan, S. Barnum et al., Equine herpesvirus-1 genotype did not significantly affect clinical signs and disease outcome in 65 horses diagnosed with equine herpesvirus-1 myeloencephalopathy, Vet. J, vol.255, p.105407, 2020.

S. Pronost, R. F. Cook, G. Fortier, P. J. Timoney, and U. B. Balasuriya, Relationship between equine herpesvirus-1 myeloencephalopathy and viral genotype: EHV-1, genotype and EHM, Equine Vet. J, vol.42, pp.672-674, 2010.

K. Shiraki, Antiviral Drugs Against Alphaherpesvirus, Adv. Exp. Med. Biol, vol.1045, pp.103-122, 2018.

A. G. Baranovskiy, N. D. Babayeva, Y. Suwa, J. Gu, Y. I. Pavlov et al., Structural basis for inhibition of DNA replication by aphidicolin, Nucleic Acids Res, vol.42, pp.1160-1183, 2014.

R. A. Bucknall, H. Moores, R. Simms, and B. Hesp, Antiviral Effects of Aphidicolin, a New Antibiotic Produced by Cephalosporium aphidicola, Antimicrob. Agents Chemother, vol.4, pp.294-298, 1973.

M. Michaelis, K. Langer, J. Vogel, J. Kreuter, H. Rabenau et al., In vitro Antiviral Activity of Aphidicolin and its Derivates. Arzneimittelforschung, vol.52, pp.393-399, 2011.

B. A. Larder and G. Darby, Susceptibility to other antiherpes drugs of pathogenic variants of herpes simplex virus selected for resistance to acyclovir, Antimicrob. Agents Chemother, vol.29, pp.894-898, 1986.

K. Zarrouk, J. Piret, and G. Boivin, Herpesvirus DNA polymerases: Structures, functions and inhibitors, Virus Res, vol.234, pp.177-192, 2017.

S. Liu, J. D. Knafels, J. S. Chang, G. A. Waszak, E. T. Baldwin et al., Crystal Structure of the Herpes Simplex Virus 1 DNA Polymerase, J. Biol. Chem, vol.281, pp.18193-18200, 2006.

A. J. Berdis, Inhibiting DNA Polymerases as a Therapeutic Intervention against, Cancer. Front. Mol. Biosci, 2017.

C. Thieulent, E. S. Hue, G. Sutton, C. Fortier, P. Dallemagne et al., Identification of antiviral compounds against equid herpesvirus-1 using real-time cell assay screening: Efficacy of decitabine and valganciclovir alone or in combination, Antivir. Res, vol.183, 2020.

S. Kasem, M. H. Yu, S. Yamada, A. Kodaira, T. Matsumura et al., The ORF37 (UL24) is a neuropathogenicity determinant of equine herpesvirus 1 (EHV-1) in the mouse encephalitis model, Virology, vol.400, pp.259-270, 2010.

A. Pearson and D. M. Coen, Identification, Localization, and Regulation of Expression of the UL24 Protein of Herpes Simplex Virus Type 1, vol.76, pp.10821-10828, 2002.

G. A. Leiva-torres, P. A. Rochette, and A. Pearson, Differential importance of highly conserved residues in UL24 for herpes simplex virus 1 replication in vivo and reactivation, J. Gen. Virol, vol.91, pp.1109-1116, 2010.
URL : https://hal.archives-ouvertes.fr/pasteur-00819557

J. G. Jacobson, S. L. Martin, and D. M. Coen, A conserved open reading frame that overlaps the herpes simplex virus thymidine kinase gene is important for viral growth in cell culture, J. Virol, vol.63, pp.1839-1843, 1989.

C. Sanabria-solano, C. E. Gonzalez, N. Richerioux, L. Bertrand, S. Dridi et al., Regulation of viral gene expression by the herpes simplex virus 1 UL24 protein (HSV-1 UL24 inhibits accumulation of viral transcripts), Virology, vol.495, pp.148-160, 2016.
URL : https://hal.archives-ouvertes.fr/pasteur-01351545

S. Dridi, N. Richerioux, C. E. Gonzalez-suarez, M. Vanharen, C. Sanabria-solano et al., A Mutation in the UL24 Gene Abolishes Expression of the Newly Identified UL24.5 Protein of Herpes Simplex Virus 1 and Leads to an Increase in Pathogenicity in Mice, J. Virol, vol.92, pp.671-689, 2018.

G. Hussey, L. S. Goehring, D. P. Lunn, S. B. Hussey, T. Huang et al., Experimental infection with equine herpesvirus type 1 (EHV-1) induces chorioretinal lesions, Vet. Res, vol.44, 2013.

L. S. Goehring, C. Van-maanen, M. Berendsen, A. Cullinane, R. J. De-groot et al., Experimental infection with neuropathogenic equid herpesvirus type 1 (EHV-1) in adult horses, Vet. J, vol.186, pp.180-187, 2010.

G. P. Allen, Risk factors for development of neurologic disease after experimental exposure to equine herpesvirus-1 in horses, Am. J. Vet. Res, vol.69, pp.1595-1600, 2008.

K. Smith, K. Whitwell, J. Mumford, D. Hannant, A. Blunden et al., Virulence of the V592 Isolate of Equid Herpesvirus-1 in Ponies, J. Comp. Pathol, vol.122, pp.288-297, 2000.

, This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license, © 2020 by the authors. Licensee MDPI